[HTML][HTML] From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress

B Dewdney, MR Jenkins, SA Best, S Freytag… - … and Targeted Therapy, 2023 - nature.com
Glioblastoma, a rare, and highly lethal form of brain cancer, poses significant challenges in
terms of therapeutic resistance, and poor survival rates for both adult and paediatric patients …

[HTML][HTML] MET in glioma: signaling pathways and targeted therapies

F Cheng, D Guo - Journal of Experimental & Clinical Cancer Research, 2019 - Springer
Gliomas represent the most common type of malignant brain tumor, among which,
glioblastoma remains a clinical challenge with limited treatment options and dismal …

[HTML][HTML] Disorders of cancer metabolism: The therapeutic potential of cannabinoids

D Sun, X Li, S Nie, J Liu, S Wang - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Abnormal energy metabolism, as one of the important hallmarks of cancer, was induced by
multiple carcinogenic factors and tumor-specific microenvironments. It comprises aerobic …

[HTML][HTML] Research progress on the regulation mechanism of key signal pathways affecting the prognosis of glioma

H Wu, M Wei, Y Li, Q Ma, H Zhang - Frontiers in Molecular …, 2022 - frontiersin.org
As is known to all, glioma, a global difficult problem, has a high malignant degree, high
recurrence rate and poor prognosis. We analyzed and summarized signal pathway of the …

Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c‐Jun signaling pathway

Z Huang, Y Xia, K Hu, S Zeng, L Wu… - Journal of …, 2020 - Wiley Online Library
Abstract Histone deacetylase 6 (HDAC6) activity contributes to the malignant proliferation,
invasion, and migration of glioma cells (GCs), but the molecular mechanisms underlying the …

The role of EGFR-met interactions in the pathogenesis of glioblastoma and resistance to treatment

G Guo, RN Narayan, L Horton… - Current cancer drug …, 2017 - ingentaconnect.com
Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. It is a
devastating and intractable disease with a poor outcome. Aberrant receptor tyrosine kinase …

Rho GDI β promotes Sp1/MMP‐2 expression and bladder cancer invasion through perturbing miR‐200c‐targeted JNK 2 protein translation

H Huang, H Jin, H Zhao, J Wang, X Li, H Yan… - Molecular …, 2017 - Wiley Online Library
Our most recent studies demonstrate that Rho GDI β is able to promote human bladder
cancer (BC) invasion and metastasis in an X‐link inhibitor of apoptosis protein‐dependent …

MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma

Y Wang, Y Xia, K Hu, M Zeng, C Zhi… - … journal of cancer, 2019 - Wiley Online Library
JNK activity has been implicated in the malignant proliferation, invasion and drug‐resistance
of glioma cells (GCs), but the molecular mechanisms underlying JNK activation are currently …

β1 integrin-mediated signaling regulates MT1-MMP phosphorylation to promote tumor cell invasion

OR Grafinger, G Gorshtein, T Stirling… - Journal of cell …, 2020 - journals.biologists.com
Malignant cancer cells can invade extracellular matrix (ECM) through the formation of F-
actin-rich subcellular structures termed invadopodia. ECM degradation at invadopodia is …

[HTML][HTML] Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival

YM Chen, M Leibovitch, M Zeinieh, N Jabado, P Brodt - Pharmaceuticals, 2023 - mdpi.com
Pediatric high-grade gliomas (pHGG) accounts for approximately 8–12% of primary brain
tumors in children. Prognosis is poor, with a median survival of 9–15 months. Insulin-like …